Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo- and Active-Controlled (Ciclesonide Metered-Dose Inhaler), Randomized, Parallel-Group, Dose-Range Finding Study of Ciclesonide Administered by Dry Powder Inhaler (Ultrahaler) in Adult and Adolescent Patients With Persistent Asthma

NCT00174746 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00174746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo- and Active-Controlled (Ciclesonide Metered-Dose Inhaler), Randomized, Parallel-Group, Dose-Range Finding Study of Ciclesonide Administered by Dry Powder Inhaler (Ultrahaler) in Adult and Adolescent Patients With Persistent Asthma
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2005
Completion date
November 30, 2005
Enrollment
1,145 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma